First Time Loading...

Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 229.45 USD 0.72%
Updated: Apr 26, 2024

Wall Street
Price Targets

CRL Price Targets Summary
Charles River Laboratories International Inc

Wall Street analysts forecast CRL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRL is 276.21 USD with a low forecast of 237.35 USD and a high forecast of 315 USD.

Lowest
Price Target
237.35 USD
3% Upside
Average
Price Target
276.21 USD
20% Upside
Highest
Price Target
315 USD
37% Upside

CRL Last Price Targets
Charles River Laboratories International Inc

The latest public price target was made on Apr 1, 2024 by Elizabeth Anderson from Evercore ISI , who expects CRL stock to rise by 31% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Elizabeth Anderson
Evercore ISI
300 USD
Upside 31%
3 weeks ago
Apr 1, 2024
Charles River Labs (CRL) PT Raised to $300 at Evercore ISI
StreetInsider
Elizabeth Anderson
Evercore ISI
Price Target 300 USD
Upside/Downside 31%
View Source
Charles River Laboratories International Inc Competitors:
Price Targets
ABCL
Abcellera Biologics Inc
320% Upside
CTKB
Cytek Biosciences Inc
81% Upside
BROOKS
Brooks Laboratories Ltd
51% Downside
GXI
Gerresheimer AG
31% Upside
301333
R&G PharmaStudies Co Ltd
85% Upside
ABSI
Absci Corp
92% Upside
DIVISLAB
Divi's Laboratories Ltd
17% Downside
RVTY
Revvity Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's revenue is 15%. The projected CAGR for the next 3 years is 6%.

15%
Past Growth
6%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's operating income is 14%. The projected CAGR for the next 3 years is 17%.

14%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's net income is 16%. The projected CAGR for the next 3 years is 15%.

16%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRL's stock price target?
Price Target
276.21 USD

According to Wall Street analysts, the average 1-year price target for CRL is 276.21 USD with a low forecast of 237.35 USD and a high forecast of 315 USD.

What is Charles River Laboratories International Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's revenue is 15%. The projected CAGR for the next 3 years is 6%.

What is Charles River Laboratories International Inc's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's operating income is 14%. The projected CAGR for the next 3 years is 17%.

What is Charles River Laboratories International Inc's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's net income is 16%. The projected CAGR for the next 3 years is 15%.